Clinical Management of Poly-D,L-Lactic Acid Nodules: A Guideline With Diagnostic and Treatment Flowchart
Fabiano Nadson Magacho-Vieira,
Eliza Porciuncula Justo Ducati,
Corresponding Author
Fabiano Nadson Magacho-Vieira
Magacho Institute for Health Education, Fortaleza, Ceará, Brazil
Department of Clinical, Aesthetic and Surgical Dermatology, Batista Memorial Hospital, Fortaleza, Ceará, Brazil
Correspondence:
Fabiano Nadson Magacho-Vieira ([email protected])
Search for more papers by this authorEliza Porciuncula Justo Ducati
ED Ultrassonografia Dermatológica, São Paulo, São Paulo, Brazil
Search for more papers by this authorFabiano Nadson Magacho-Vieira,
Eliza Porciuncula Justo Ducati,
Corresponding Author
Fabiano Nadson Magacho-Vieira
Magacho Institute for Health Education, Fortaleza, Ceará, Brazil
Department of Clinical, Aesthetic and Surgical Dermatology, Batista Memorial Hospital, Fortaleza, Ceará, Brazil
Correspondence:
Fabiano Nadson Magacho-Vieira ([email protected])
Search for more papers by this authorEliza Porciuncula Justo Ducati
ED Ultrassonografia Dermatológica, São Paulo, São Paulo, Brazil
Search for more papers by this authorFirst published: 31 March 2025
Funding: The authors received no specific funding for this work.
Conflicts of Interest
F.N.M.-V. serves as medical director for Dermadream Corporation. E.P.J.D. is a regular speaker for Dermadream Corporation.
Open Research
Data Availability Statement
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
References
- 1Y. A. No, J. Seok, M. Y. Hyun, et al., “Long-Term (24-Month) Safety Evaluation of Poly-DL-Lactic Acid Filler Injection for the Nasolabial Fold: A Multicenter, Open, Randomized, Evaluator-Blind, Active-Controlled Design,” Plastic and Reconstructive Surgery 135, no. 6 (2015): 1074e–1075e, https://doi.org/10.1097/PRS.0000000000001247.
- 2F. N. Magacho-Vieira and A. P. Santana, “Displacement of Hyaluronic Acid Dermal Filler Mimicking a Cutaneous Tumor: A Case Report,” Clinical, Cosmetic and Investigational Dermatology 16 (2023): 197–201, https://doi.org/10.2147/CCID.S398014.
- 3X. Wortsman, “Identification and Complications of Cosmetic Fillers: Sonography First,” Journal of Ultrasound in Medicine 34, no. 7 (2015): 1163–1172, https://doi.org/10.7863/ultra.34.7.1163.
- 4T. R. Kwon, S. W. Han, I. K. Yeo, et al., “Biostimulatory Effects of Polydioxanone, Poly- d, l Lactic Acid, and Polycaprolactone Fillers in Mouse Model,” Journal of Cosmetic Dermatology 18, no. 4 (2019): 1002–1008, https://doi.org/10.1111/jocd.12950.
- 5K. M. Perez Willis and G. R. Ramirez, “Granuloma After the Injection of Poly-D,L-Lactic Acid (PDLLA) Treated With Triamcinolone,” Case Reports in Dermatological Medicine 2024 (2024): 6544506, https://doi.org/10.1155/2024/6544506.
- 6G. W. Hong, H. Hu, K. Chang, et al., “Review of the Adverse Effects Associated With Dermal Filler Treatments: Part I Nodules, Granuloma, and Migration,” Diagnostics 14, no. 15 (2024): 1640, https://doi.org/10.3390/diagnostics14151640.
- 7A. G. Nicola, M. O. Pricop, and B. Ramos-Medina, “Clinical Management With High-Frequency Ultrasound of Recurrent Submental Abscess Formation After Filler Placement: Bacterial Contamination or Immune-Mediated Adverse Event?,” Cureus 16, no. 4 (2024): e58878, https://doi.org/10.7759/cureus.58878.
- 8E. Davies, D. Vaghela, C. Convery, L. Walker, and G. Murray, “Guideline for the Prevention, Diagnosis, and Management of Acute Bacterial Soft Tissue Infections Following Nonsurgical Cosmetic Procedures,” Journal of Clinical and Aesthetic Dermatology 14, no. Suppl 1 (2021): S29–S35.
- 9R. S. Narins, M. Jewell, M. Rubin, J. Cohen, and J. Strobos, “Clinical Conference: Management of Rare Events Following Dermal Fillers—Focal Necrosis and Angry Red Bumps,” Dermatologic Surgery 32, no. 3 (2006): 426–434, https://doi.org/10.1111/j.1524–4725.2006.32086.x.
- 10W. Baranska-Rybak, J. V. Lajo-Plaza, L. Walker, and N. Alizadeh, “Late-Onset Reactions After Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention, and Management,” Dermatologic Therapy 14, no. 7 (2024): 1767–1785, https://doi.org/10.1007/s13555-024-01202-3.
10.1007/s13555-024-01202-3 Google Scholar
- 11Y. L. Zhang, Z. S. Sun, W. J. Hong, Y. Chen, Y. F. Zhou, and S. K. Luo, “Biofilm Formation Is a Risk Factor for Late and Delayed Complications of Filler Injection,” Frontiers in Microbiology 14 (2024): 1297948, https://doi.org/10.3389/fmicb.2023.1297948.
- 12C. Convery, E. Davies, G. Murray, and L. Walker, “Delayed-Onset Nodules (DONs) and Considering Their Treatment Following Use of Hyaluronic Acid (HA) Fillers,” Journal of Clinical and Aesthetic Dermatology 14, no. 7 (2021): E59–E67.
- 13G. Munhoz, F. A. Cavallieri, L. K. de Almeida Balassiano, et al., “Sterile Abscess due to Hyaluronic Acid: A New Diagnosis and a Proposal for Treatment-A Series of Eight Cases,” Journal of Cosmetic Dermatology 21, no. 11 (2022): 5562–5568, https://doi.org/10.1111/jocd.15135.
- 14A. D. McCarthy, J. van Loghem, K. A. Martinez, S. B. Aguilera, and D. Funt, “A Structured Approach for Treating Calcium Hydroxylapatite Focal Accumulations,” Aesthetic Surgery Journal 44, no. 8 (2024): 869–879, https://doi.org/10.1093/asj/sjae031.
- 15F. A. Cavallieri, L. K. A. Balassiano, G. Munhoz, M. F. Tembra, and X. Wortsman, “Ultrasound in Aesthetics: Filler and Non-Filler Applications,” Seminars in Ultrasound, CT, and MR 45, no. 3 (2024): 251–263, https://doi.org/10.1053/j.sult.2023.11.005.
- 16S. B. Seo, J. Wan, and K. H. Yi, “Energy-Based Device Management of Nodular Reaction Following Poly-D,L-Lactic Acid Injection for Tear Trough Rejuvenation,” Journal of Cosmetic Dermatology 24 (2025): e16575, https://doi.org/10.1111/jocd.16575.
- 17J. Herzstein and M. Ebell, “Improving Quality by Doing Less: Overtreatment,” American Family Physician 91, no. 5 (2015): 289–291.
